Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma
Daniel J. Zabransky(Johns Hopkins University), Mark Yarchoan(Johns Hopkins University)
Cited by 9
Related Papers
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
|Nature Immunology|2024|84
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
|Cancer Research|2024|29